Zhou, Xu
Yan, Dong-mei
Zhu, Wei-feng
Liu, Wen-jun
Nie, He-yun
Xu, Sheng
Jiang, Yi-ping
Zhang, Kun-he
Fu, Ying
Wan, Yi-ye
Yu, Xin-yu
Li, Hong
Sun, Xin
Chen, Xiao-fan http://orcid.org/0000-0001-6639-1313
Funding for this research was provided by:
Health and Family Planning Commission of Jiangxi Province (2016B028)
“1050” Young Talents Project and Scientific of Jiangxi University of Traditional Chinese Medicine (207/1141900102)
Jiangzhong Pharmaceutical (group) Co., Ltd (2016918)
Article History
Received: 27 September 2018
Accepted: 13 May 2019
First Online: 10 June 2019
Ethics approval and consent to participate
: This study has been approved by the ethics committees in Affiliated Hospital of Jiangxi University of Traditional Chinese Medicine (No. JZFYLL2016093010), First Affiliated Hospital of Nanchang University (No. 2016047), Second Affiliated Hospital of Nanchang University (No. 2016YYLS10), and Jiangxi Provincial Cancer Hospital (No. 2016013-KY011). The trial will be conducted in compliance with the Declaration of Helsinki and the principles of Good Clinical Practice. The protocol was registered at ClinicalTrials.gov (NCT03025152) on January 17, 2017. Written informed consent will be obtained from all volunteers, and the study will conform to the ethical principles set forth by the Declaration of Helsinki.
: Not applicable.
: The authors declare that they have no competing interests.